• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ST-Segment Elevation Myocardial Infarction (STEMI) and Pulmonary Embolism in a Hemophilia A Patient Receiving Emicizumab and recombinant Activated Factor VII.

作者信息

Gundabolu Krishna, Goldsweig Andrew, Bhatt Vijaya R, Koepsell Scott A, Harper James L

机构信息

Department of Hematology-Oncology, University of Nebraska Medical Center, Omaha, NE, USA.

Department of Cardiovascular Medicine, University of Nebraska Medical Center, Omaha, NE, USA.

出版信息

Haemophilia. 2020 Jan;26(1):e5-e8. doi: 10.1111/hae.13871. Epub 2019 Nov 6.

DOI:10.1111/hae.13871
PMID:31694063
Abstract
摘要

相似文献

1
ST-Segment Elevation Myocardial Infarction (STEMI) and Pulmonary Embolism in a Hemophilia A Patient Receiving Emicizumab and recombinant Activated Factor VII.一名接受艾美赛珠单抗和重组活化凝血因子 VII 治疗的甲型血友病患者发生 ST 段抬高型心肌梗死（STEMI）和肺栓塞
Haemophilia. 2020 Jan;26(1):e5-e8. doi: 10.1111/hae.13871. Epub 2019 Nov 6.
2
Reduced plasma factor X is associated with a lack of response to recombinant activated factor VII in patients with hemophilia A and inhibitor, but does not impair emicizumab-driven hemostasis in vitro.血浆因子 X 减少与接受重组活化因子 VII 治疗的血友病 A 伴抑制物患者无反应相关，但不影响体外emicizumab 介导的止血作用。
Thromb Res. 2024 May;237:37-45. doi: 10.1016/j.thromres.2024.03.023. Epub 2024 Mar 22.
3
Spinal epidural hematoma in a child with hemophilia A with high titer inhibitors and follow-up with prophylactic emicizumab: case report and literature review.血友病 A 患儿伴高滴度抑制剂的脊柱硬膜外血肿：病例报告和文献复习。
Blood Coagul Fibrinolysis. 2021 Sep 1;32(6):418-422. doi: 10.1097/MBC.0000000000001038.
4
Consecutive complex percutaneous coronary interventions using emicizumab and recombinant activated factor VII in a patient with severe haemophilia A and high-titre inhibitor.在一名患有严重甲型血友病且高滴度抑制物的患者中连续使用emicizumab和重组活化因子VII进行复杂经皮冠状动脉介入治疗。
Haemophilia. 2021 May;27(3):e385-e388. doi: 10.1111/hae.14165. Epub 2020 Sep 30.
5
Emicizumab for the treatment of haemophilia A: a narrative review.依库珠单抗治疗 A 型血友病：一篇叙述性综述。
Blood Transfus. 2019 May;17(3):223-228. doi: 10.2450/2019.0026-19.
6
Emicizumab should be prescribed independent of immune tolerance induction.依库珠单抗的使用不应依赖于免疫耐受诱导。
Blood Adv. 2018 Oct 23;2(20):2783-2786. doi: 10.1182/bloodadvances.2018015859.
7
Emicizumab Prophylaxis in Hemophilia A with Inhibitors.依库珠单抗预防伴抑制物的血友病 A。
N Engl J Med. 2017 Aug 31;377(9):809-818. doi: 10.1056/NEJMoa1703068. Epub 2017 Jul 10.
8
Initiation of emicizumab prophylaxis in an infant with haemophilia A and subdural haemorrhage.对一名患有甲型血友病和硬膜下出血的婴儿开始使用emicizumab进行预防治疗。
Haemophilia. 2020 Nov;26(6):e353-e355. doi: 10.1111/hae.14133. Epub 2020 Sep 6.
9
Safety first: Tracking adverse events associated with new therapies for people with hemophilia.安全第一：追踪与血友病患者新疗法相关的不良事件。
J Thromb Haemost. 2021 Jan;19 Suppl 1:3-5. doi: 10.1111/jth.15188.
10
Major surgery management in patients with haemophilia A and inhibitors on emicizumab prophylaxis without global coagulation monitoring.在接受emicizumab预防治疗且无全面凝血监测的甲型血友病和抑制剂患者中的大手术管理
Br J Haematol. 2020 May;189(3):e100-e103. doi: 10.1111/bjh.16512. Epub 2020 Feb 22.

引用本文的文献

1
Coronary Revascularization in Patients with Hemophilia and Acute Coronary Syndrome: Case Report and Brief Literature Review.血友病合并急性冠状动脉综合征患者的冠状动脉血运重建：病例报告及文献简要综述
J Clin Med. 2025 Jun 11;14(12):4130. doi: 10.3390/jcm14124130.
2
Emicizumab is well tolerated and effective in people with congenital hemophilia A regardless of age, severity of disease, or inhibitor status: a scoping review.依美珠单抗耐受性良好，对先天性A型血友病患者有效，无论其年龄、疾病严重程度或抑制剂状态如何：一项范围综述。
Res Pract Thromb Haemost. 2024 Apr 18;8(4):102415. doi: 10.1016/j.rpth.2024.102415. eCollection 2024 May.
3
Emicizumab prophylaxis in people with hemophilia A and inhibitors: a systematic review and meta-analysis.
依库珠单抗预防血友病 A 伴抑制物患者出血：系统评价和荟萃分析。
Sao Paulo Med J. 2024 May 10;142(5):e2023102. doi: 10.1590/1516-3180.2023.0102.R1.20022024. eCollection 2024.
4
Management of surgery in persons with hemophilia A receiving emicizumab prophylaxis: data from a national hemophilia treatment center.接受艾美赛珠单抗预防治疗的甲型血友病患者的手术管理：来自一个国家血友病治疗中心的数据。
Res Pract Thromb Haemost. 2023 Aug 23;7(6):102178. doi: 10.1016/j.rpth.2023.102178. eCollection 2023 Aug.
5
Between Scylla and Charybdis: thrombosis in children with hemophilia.进退两难：血友病患儿的血栓形成
Front Pediatr. 2023 May 23;11:1173549. doi: 10.3389/fped.2023.1173549. eCollection 2023.
6
Current Therapeutic Approach to Acute Myocardial Infarction in Patients with Congenital Hemophilia.先天性血友病患者急性心肌梗死的当前治疗方法
Life (Basel). 2021 Oct 11;11(10):1072. doi: 10.3390/life11101072.
7
Twelve months of emicizumab prophylaxis in a severe hemophilia A man with inhibitor who failed immune tolerance induction: effectiveness, economic, and safety outcomes.对一名重度甲型血友病且产生抑制剂、免疫耐受诱导失败的男性进行12个月的emicizumab预防治疗：疗效、经济性和安全性结果。
Hematol Transfus Cell Ther. 2023 Jan-Mar;45(1):98-101. doi: 10.1016/j.htct.2021.02.010. Epub 2021 May 7.